- Previous Close
108.10 - Open
108.85 - Bid 107.95 x --
- Ask 108.80 x --
- Day's Range
107.40 - 109.95 - 52 Week Range
99.95 - 143.50 - Volume
6,978 - Avg. Volume
8,155 - Market Cap (intraday)
3.898B - Beta (5Y Monthly) 1.15
- PE Ratio (TTM)
-- - EPS (TTM)
-0.79 - Earnings Date Jul 31, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.
www.lykalabs.comRecent News: LYKALABS.BO
Performance Overview: LYKALABS.BO
Trailing total returns as of 6/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LYKALABS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LYKALABS.BO
Valuation Measures
Market Cap
3.88B
Enterprise Value
4.38B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.08
Price/Book (mrq)
5.70
Enterprise Value/Revenue
3.94
Enterprise Value/EBITDA
26.11
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.24%
Return on Assets (ttm)
1.18%
Return on Equity (ttm)
-4.60%
Revenue (ttm)
1.11B
Net Income Avi to Common (ttm)
-24.89M
Diluted EPS (ttm)
-0.79
Balance Sheet and Cash Flow
Total Cash (mrq)
59.66M
Total Debt/Equity (mrq)
85.91%
Levered Free Cash Flow (ttm)
-102.97M